Millennium Management’s Xenon Pharmaceuticals XENE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$27.6M Buy
882,835
+648,779
+277% +$20.3M 0.01% 902
2025
Q1
$7.85M Sell
234,056
-111,984
-32% -$3.76M ﹤0.01% 1679
2024
Q4
$13.6M Buy
346,040
+137,014
+66% +$5.37M 0.01% 1353
2024
Q3
$8.23M Buy
209,026
+33,442
+19% +$1.32M ﹤0.01% 1663
2024
Q2
$6.85M Buy
175,584
+91,923
+110% +$3.58M ﹤0.01% 1716
2024
Q1
$3.6M Buy
83,661
+6,696
+9% +$288K ﹤0.01% 2224
2023
Q4
$3.55M Sell
76,965
-18,528
-19% -$853K ﹤0.01% 2116
2023
Q3
$3.26M Sell
95,493
-117,845
-55% -$4.03M ﹤0.01% 2186
2023
Q2
$8.21M Sell
213,338
-8,132
-4% -$313K ﹤0.01% 1602
2023
Q1
$7.93M Sell
221,470
-373,071
-63% -$13.4M ﹤0.01% 1600
2022
Q4
$23.4M Buy
594,541
+34,192
+6% +$1.35M 0.01% 906
2022
Q3
$20.2M Buy
560,349
+67,658
+14% +$2.44M 0.01% 914
2022
Q2
$15M Buy
492,691
+356,365
+261% +$10.8M 0.01% 1137
2022
Q1
$4.17M Buy
136,326
+45,705
+50% +$1.4M ﹤0.01% 2447
2021
Q4
$2.83M Sell
90,621
-145,598
-62% -$4.55M ﹤0.01% 2686
2021
Q3
$3.61M Sell
236,219
-65,529
-22% -$1M ﹤0.01% 2505
2021
Q2
$5.62M Sell
301,748
-41,151
-12% -$766K ﹤0.01% 2013
2021
Q1
$6.14M Sell
342,899
-73,576
-18% -$1.32M ﹤0.01% 1885
2020
Q4
$6.41M Buy
416,475
+297,630
+250% +$4.58M ﹤0.01% 1713
2020
Q3
$1.32K Sell
118,845
-49,151
-29% -$544 ﹤0.01% 2312
2020
Q2
$2.11M Sell
167,996
-25,573
-13% -$321K ﹤0.01% 1989
2020
Q1
$2.2M Buy
193,569
+145,855
+306% +$1.65M ﹤0.01% 1576
2019
Q4
$626K Buy
+47,714
New +$626K ﹤0.01% 2632
2019
Q2
Sell
-48,286
Closed -$491K 3829
2019
Q1
$491K Sell
48,286
-97,096
-67% -$987K ﹤0.01% 2790
2018
Q4
$917K Buy
145,382
+62,509
+75% +$394K ﹤0.01% 2308
2018
Q3
$1.09M Buy
+82,873
New +$1.09M ﹤0.01% 2491
2017
Q1
Sell
-193,674
Closed -$1.49M 3580
2016
Q4
$1.49M Buy
+193,674
New +$1.49M ﹤0.01% 1872